Add new comment

I hate to be a downer but I can kind of see where the company is coming from. Organs are a scarce resource and transplants are expensive with all the immunosuppressants. Putting all those resources into a patient who was probably going to die anyway is a waste of a perfectly good liver.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.